ArticleDrug and alcohol review2026
A Quantitative Analysis of Street-Level Drugs Seized in New South Wales, Australia: Purity, Dose and Adulterants.
Article in Drug and alcohol review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe Combined Surveillance and Monitoring of Seized Samples (CoSMoSS) program is a joint harm reduction initiative between NSW Health and NSW Police Force. Here, we examine the contents and purity of a sample of seized suspected target drugs (cocaine, heroin, methamphetamine and 3,4-methylenedioxymethamphetamine 'MDMA').
methodsBetween January 2021 and March 2025, 3378 street drug samples seized during routine operations by NSW Police Force within music festivals or specified geographic regions and suspected by police to contain a target drug were selected for expedited quantitative analysis with GC-MS, with results available within 1 month.
resultsAs expected, most samples contained at least one target drug. About 1 in 6 samples (16.5%) were found to contain at least one adulterant and 3.9% of samples contained a novel psychoactive substance, including dipentylone, nitazenes, fentanyl analogues and novel benzodiazepines. Purity information is presented; median MDMA tablet dose was 104 mg and capsule dose was 64 mg (free base) and was higher in more recent years. DISCUSSION AND
conclusionsSome rarer substances with higher or unknown risk potential, including novel psychoactive substance, were detected. Adulteration of cocaine and methamphetamine with opioids and high variability in MDMA purity and dose, remain public health issues. CoSMoSS helps inform harm reduction messaging. Analysis of seized substances provides high-quality objective information about illicit drug contents and purity, enabling dissemination to the community when high risk substances are identified. These findings can also inform harm reduction messaging and programs and are monitored within the NSW Health drug early warning system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.